Name
GREATER IMPROVEMENTS IN BILIRUBIN WERE OBSERVED IN PRURITUS RESPONDERS AFTER MARALIXIBAT TREATMENT IN PATIENTS WITH PFIC: DATA FROM THE MARCH/MARCH-ON TRIALS
Topic
Other liver disease - Clinical Science, Epidemiology & Public Health
Group
CLM
Number
P-148
Presenter
Tony Tokman